Orhan Aktas Selected Research

Orhan Aktas Research Topics

Disease

61	Multiple Sclerosis 01/2022 - 02/2002
38	Neuromyelitis Optica (Devic's Disease) 01/2022 - 04/2007
21	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 01/2012
15	Relapsing-Remitting Multiple Sclerosis 01/2021 - 04/2008
14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2019 - 03/2003
11	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 12/2003
10	Ganglion Cysts (Ganglion) 01/2022 - 01/2012
9	Inflammation (Inflammations) 01/2022 - 03/2003
8	Myelitis 09/2020 - 07/2015
7	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 02/2002
7	Neuroinflammatory Diseases 01/2019 - 12/2003
6	Infections 10/2020 - 08/2005
5	Atrophy 01/2022 - 07/2017
5	Disease Progression 01/2022 - 01/2003
4	Encephalitis (Encephalitis, Rasmussen) 09/2020 - 01/2016
4	Encephalomyelitis (Myeloencephalitis) 09/2020 - 03/2003
4	Susac Syndrome 12/2016 - 01/2012
3	Pain (Aches) 01/2022 - 07/2015
3	Polyneuropathies (Polyneuropathy) 01/2022 - 10/2016
3	Chronic Progressive Multiple Sclerosis 10/2020 - 10/2009
3	Leukocytosis (Pleocytosis) 11/2016 - 01/2012
3	Neoplasms (Cancer) 10/2016 - 05/2007
3	Transverse Myelitis (Necrotizing Myelitis) 01/2016 - 04/2007
2	COVID-19 01/2022 - 01/2021
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 01/2019
2	Lymphopenia (Lymphocytopenia) 01/2021 - 04/2020
2	Rheumatoid Arthritis 10/2020 - 03/2013
2	Progressive Multifocal Leukoencephalopathy 10/2020 - 08/2019
2	Ischemic Stroke 09/2020 - 01/2019
2	Rubella (German Measles) 09/2020 - 09/2020
2	Herpes Zoster 09/2020 - 09/2020
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 09/2020 - 09/2020
2	Measles 09/2020 - 09/2020
2	Stroke (Strokes) 09/2020 - 01/2019
2	Headache (Headaches) 04/2020 - 10/2019
2	Infarction (Infarctions) 01/2020 - 08/2015
2	Paralysis (Palsy) 10/2019 - 03/2003
2	Hypersensitivity (Allergy) 03/2017 - 08/2008
2	Vision Disorders (Hemeralopia) 11/2016 - 09/2015
2	Retinal Artery Occlusion 08/2015 - 06/2013
2	Meningitis 02/2015 - 07/2007
2	Brain Diseases (Brain Disorder) 02/2007 - 11/2004
1	Post-Acute COVID-19 Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 01/2022 - 01/2012
17	Immunoglobulin G (IgG)IBA 01/2022 - 05/2007
14	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 01/2011
13	AntibodiesIBA 01/2021 - 04/2007
9	Oligoclonal BandsIBA 01/2022 - 01/2012
7	ocrelizumabIBA 01/2022 - 08/2020
7	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 07/2010
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
5	tocilizumab (atlizumab)FDA Link 01/2022 - 03/2013
5	AutoantibodiesIBA 01/2022 - 10/2016
5	Aquaporin 4IBA 01/2021 - 04/2007
5	Monoclonal AntibodiesIBA 01/2021 - 03/2013
5	Natalizumab (Tysabri)FDA Link 01/2021 - 02/2012
5	Proteins (Proteins, Gene)FDA Link 09/2020 - 04/2007
5	LigandsIBA 07/2007 - 02/2002
4	CytokinesIBA 01/2022 - 08/2005
4	inebilizumabIBA 01/2022 - 10/2019
4	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 01/2003
4	InterferonsIBA 10/2020 - 12/2014
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2012
4	opicinumabIBA 12/2018 - 01/2016
4	AntigensIBA 01/2018 - 04/2007
4	anti-aquaporin 4 autoantibodyIBA 07/2017 - 01/2012
4	Aquaporins (Water Channels)IBA 01/2016 - 02/2012
3	Rituximab (Mabthera)FDA Link 01/2022 - 10/2020
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022 - 03/2013
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 11/2004
3	Interferon-betaIBA 01/2019 - 06/2003
3	Peptides (Polypeptides)IBA 01/2019 - 01/2003
3	IntegrinsIBA 01/2015 - 12/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008 - 03/2003
3	Atorvastatin (Lipitor)FDA Link 04/2008 - 03/2003
2	GlutaredoxinsIBA 01/2022 - 01/2017
2	Biological ProductsIBA 01/2021 - 10/2020
2	GadoliniumIBA 01/2021 - 05/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 11/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2019
2	Immunoglobulin M (IgM)IBA 09/2020 - 09/2020
2	Immunoglobulin IsotypesIBA 09/2020 - 09/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2020 - 09/2020
2	AlbuminsIBA 09/2020 - 09/2020
2	Immunoglobulin A (IgA)IBA 09/2020 - 09/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2019 - 01/2003
2	Alemtuzumab (Campath)FDA Link 11/2018 - 01/2015
2	Erythropoietin FDA Link 03/2016 - 01/2016
2	CholesterolIBA 07/2015 - 12/2003
2	MicroRNAs (MicroRNA)IBA 01/2015 - 05/2014
2	CopperIBA 04/2012 - 01/2012
2	Cladribine FDA LinkGeneric 01/2012 - 02/2010
2	NF-kappa B (NF-kB)IBA 08/2008 - 11/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 05/2005
2	TNF-Related Apoptosis-Inducing LigandIBA 07/2007 - 06/2003
1	dimemorfan (AT 17)IBA 01/2022

Therapy/Procedure

32	Therapeutics 08/2021 - 01/2003
6	Immunotherapy 01/2022 - 01/2017
4	Immunomodulation 01/2022 - 01/2003
2	Plasma Exchange 11/2018 - 11/2016